Soligenix Announces Partial Adjournment of Annual Meeting and Information for Reconvened Annual Meeting
/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing...
Us Congress Exchange Commission On National Institute Of Allergy Soligenix Inc Defense Threat Reduction Agency Us Development
Source: prnewswire.com